Core Viewpoint - On July 14, the Shanghai Composite Index rose by 0.27%, with institutional investors appearing on the trading lists of 35 stocks, net buying 19 and net selling 16 [1] Institutional Trading Summary - Institutional special seats net bought the most in Xiangyang Bearing, which closed at the daily limit with a turnover rate of 27.67% and a transaction amount of 2.076 billion yuan, net buying 110.74 million yuan [2] - San Chuan Wisdom closed up 15.27% with a turnover rate of 32.50%, net buying 75.27 million yuan, but had a net outflow of 35.2 million yuan [2] - Zhongke Magnetic Industry closed down 5.10% with a turnover rate of 45.77%, net buying 53.99 million yuan, but had a net outflow of 49.77 million yuan [2] Market Performance - The average increase of stocks with institutional net purchases was 2.36%, outperforming the Shanghai Composite Index [3] - Stocks like Changrong Co. and Xinling Electric showed strong performance, closing at the daily limit [3] - Historical data indicates a 52.06% probability of stocks with institutional net purchases rising the next day, and a 39.70% probability of rising in the following three days [3] Earnings Forecasts - Among the stocks with institutional net purchases, four have released half-year earnings forecasts, with Yuhua Development expected to have a net profit of 200 million yuan, a year-on-year increase of 708% [3] Net Selling Summary - The stock with the highest net selling by institutions was Siyuan Electric, with a net selling amount of 162.84 million yuan, while also seeing a net inflow of 98.77 million yuan [3] - Dazhihui was noted for a net selling of 120.24 million yuan, with a significant net outflow of 433 million yuan [4] Deep and Shanghai Stock Connect - On July 14, 15 stocks on the trading list had appearances from the Deep and Shanghai Stock Connect, with Siyuan Electric and Zhongke Jincai seeing net purchases of 139 million yuan and 113 million yuan respectively [7][8] - Stocks like Hengbao Co. and Greenland Holdings experienced significant net selling amounts of 193 million yuan and 79.38 million yuan respectively [8]

Market Overview - The Sci-Tech Innovation Board (STAR Market) index decreased by 0.21%, closing at 992.39 points, with a total trading volume of 2.875 billion shares and a turnover of 95.999 billion yuan, resulting in an average turnover rate of 1.61% [1] - Among the tradable stocks on the STAR Market, 358 stocks closed higher, with 6 stocks hitting the daily limit, while 219 stocks closed lower [1] Stock Performance - The highest turnover rate was recorded by Yitang Co., Ltd., a newly listed stock, which saw a decline of 1.86% and a turnover rate of 19.71%, with a daily transaction amount of 820 million yuan and a net outflow of 141 million yuan in main funds [1] - Other notable stocks with high turnover rates included Borui Data, which increased by 7.23% with a turnover rate of 18.73%, and Jin Chengzi, Zhongyan Co., and Saifen Technology, with turnover rates of 15.34%, 15.10%, and 14.80% respectively [1] High Turnover Stocks - Among stocks with a turnover rate exceeding 5%, 43 stocks increased in value today, with the highest gains from Zhijiang Biology (20.00%), Nanxin Pharmaceutical (18.16%), and Yanhong Pharmaceutical (17.32%) [2] - The pharmaceutical and biological sector had the most stocks with high turnover rates, totaling 20, followed by the computer and power equipment sectors with 10 and 6 stocks respectively [2] Fund Flow Analysis - In terms of fund flow, 32 stocks with high turnover rates experienced net inflows, with Zhijiang Biology, Yanhong Pharmaceutical, and Nanxin Pharmaceutical receiving the most significant net inflows of 100 million yuan, 82.6559 million yuan, and 31.76 million yuan respectively [2] - Conversely, Yitang Co., Ltd., Dingtong Technology, and Shijia Photon saw the largest net outflows, amounting to 141 million yuan, 89.163 million yuan, and 76.5522 million yuan respectively [2] Leverage Fund Movements - Recent data indicates that 37 stocks with high turnover rates received net purchases from leveraged funds, with Yitang Co., Ltd., Rongchang Biology, and Dingtong Technology seeing significant increases in financing balances of 260 million yuan, 80.9046 million yuan, and 79.4712 million yuan respectively [3] - Stocks with decreased financing balances included Youfang Technology, Yingshi Innovation, and Guangda Special Materials, with reductions of 142 million yuan, 82 million yuan, and 49.5677 million yuan respectively [3] Notable Stocks on July 14 - A list of notable stocks with high turnover rates includes: - Yitang Co., Ltd. (688729): Closing price 20.55, daily change -1.86%, turnover rate 19.71%, net outflow -140.50 million yuan [4] - Borui Data (688229): Closing price 64.55, daily change 7.23%, turnover rate 18.73%, net inflow 21.51 million yuan [4] - Jin Chengzi (688291): Closing price 35.28, daily change 1.50%, turnover rate 15.34%, net inflow 3.69 million yuan [4] - Zhongyan Co. (688716): Closing price 37.16, daily change 9.01%, turnover rate 15.10%, net inflow 24.58 million yuan [4] - Saifen Technology (688758): Closing price 17.54, daily change 3.91%, turnover rate 14.80%, net inflow 10.26 million yuan [4]

重要内容提示： 证券代码：688189 证券简称：南新制药 公告编号：2025-028 湖南南新制药股份有限公司 关于以集中竞价交易方式回购公司股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 上述股份回购符合法律法规的规定及公司回购股份方案的要求。 三、其他事项 公司将严格按照《上市公司股份回购规则》《上海证券交易所上市公司自律监 管指引第 7 号——回购股份》等相关规定，在回购期限内根据市场情况择机做出 回购决策并予以实施，同时根据回购股份事项进展情况及时履行信息披露义务， 敬请广大投资者注意投资风险。 | 回购方案首次披露日 | 2025/4/30 | | --- | --- | | 回购方案实施期限 | 2025/4/28~2026/4/27 | | 预计回购金额 | 1,000万元~2,000万元 | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 | | | □用于转换公司可转债 | | | □为维护公司价值及股东权益 | | 累计已回购股数 | 265,516股 | | 累计已回购股 ...

Meeting Overview - The shareholders' meeting of Hunan Nanxin Pharmaceutical Co., Ltd. was held on June 13, 2025, in Guangzhou, Guangdong Province [1]. - The meeting was presided over by Chairman Zhang Shixi and utilized a combination of on-site and online voting methods [1]. Attendance and Voting - A total of 56 ordinary shareholders attended the meeting, holding 80,977,423 voting rights, which represents 29.6961% of the company's total voting rights [1]. - The voting results showed a strong majority in favor of the proposals, with ordinary shareholders voting 98.1570% in favor of the first resolution [2]. Resolutions Passed - Multiple resolutions were passed during the meeting, including: - The proposal for the company to provide guarantees for its subsidiaries [3]. - The profit distribution proposal for the year 2024 [3]. - The proposal to purchase directors and supervisors' liability insurance [3]. - The proposal to cancel a subsidiary [3]. - The proposal to use excess raised funds to permanently supplement working capital [3]. Legal Compliance - The meeting's procedures, including the qualifications of attendees and the voting process, were confirmed to be in compliance with legal regulations and the company's articles of association [3].

证券代码：688189 证券简称：南新制药 公告编号：2025-027 湖南南新制药股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 6 月 13 日 （二） 股东大会召开的地点：广东省广州市黄埔区开源大道 196 号广州南新制 药有限公司 313 会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 56 | | --- | --- | | 普通股股东人数 | 56 | | 2、出席会议的股东所持有的表决权数量 | 80,977,423 | | 普通股股东所持有表决权数量 | 80,977,423 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 29.6961 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 29.6 ...

北京大成(广州)律师事务所 关于湖南南新制药股份有限公司 2024 年年度股东大会的 法律意见书 大成 DENTONS 大成 is Dentons' Preferred Law Firm in China. guangzhou.dachenglaw.com 广州市天河区珠江新城珠江东路 6 号广州周大福金融中心 14 层、15 层（510623 ） 14/F,15/F CTF Finance Centre No 6 Zhujiang East Road Tianhe District 510623, Guangzhou, China Tel:+8620-85277000 Fax:+8620-85277002 十三十成(广州) 广州市手河区珠江新城珠江东路 6 北京大成(广州)律师事务所 关于湖南南新制药股份有限公司 2024 年年度股东大会法律意见书 致:湖南南新制药股份有限公司 根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民共 和国公司法》（以下简称"《公司法》"）和中国证券监督管理委员会《上市公司 股东会规则》等法律、法规和其他有关规范性文件的要求,北京大成（广州）律 师事务所(以下简 ...

证券代码：688189 证券简称：南新制药 公告编号：2025-026 湖南南新制药股份有限公司 上述股份回购符合法律法规的规定及公司回购股份方案的要求。 关于以集中竞价交易方式回购公司股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | 回购方案首次披露日 | 2025/4/30 | | --- | --- | | 回购方案实施期限 | 2025/4/28~2026/4/27 | | 预计回购金额 | 1,000万元~2,000万元 | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 | | | □用于转换公司可转债 | | | □为维护公司价值及股东权益 | | 累计已回购股数 | 142,114股 | | 累计已回购股数占总股本比例 | 0.05% | | 累计已回购金额 | 1,003,764.13元 | | 实际回购价格区间 | 7.02元/股~7.11元/股 | 一、回购股份的基本情况 湖南南新制药股份有限公司（以下简称"公司"）于 2025 年 4 月 28 日召开第 二届董事会第十 ...

Core Viewpoint - Nanjing Pharmaceutical (688189) is expanding its marketing network and product offerings in response to market demands, particularly in the flu treatment sector, while also initiating a share buyback program to enhance shareholder value [1][2][3] Group 1: Company Performance - As of May 30, 2025, Nanjing Pharmaceutical's stock closed at 7.06 yuan, with a 1.0% increase, a turnover rate of 3.09%, a trading volume of 84,700 shares, and a transaction value of 60.0036 million yuan [1] - On the same day, the net inflow of main funds was 6.1534 million yuan, while retail investors experienced a net outflow of 6.5781 million yuan [3] Group 2: Share Buyback Announcement - The company announced its first share buyback on May 30, 2025, repurchasing 142,114 shares, which is 0.05% of the total share capital of 274.4 million shares, at a total cost of approximately 1,003,764.13 yuan [2][3] - The buyback was approved during the board meeting on April 28, 2025, with a planned budget of between 10 million and 20 million yuan, and a maximum buyback price set at 9.53 yuan per share, to be completed within 12 months [2]

证券代码：688189 证券简称：南新制药 公告编号：2025-025 湖南南新制药股份有限公司 二、首次实施回购股份的基本情况 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关规定，现将公司首次回购股份情况公告如下： 2025 年 5 月 30 日，公司以集中竞价交易方式首次回购公司股份 142,114 股， 占公司总股本 274,400,000 股的比例为 0.05%，回购成交的最高价为 7.11 元/股， 最低价为 7.02 元/股，支付的资金总额为人民币 1,003,764.13 元（不含印花税、 交易佣金等交易费用）。 上述股份回购符合法律法规的规定及公司回购股份方案的要求。 三、其他事项 关于以集中竞价交易方式首次回购公司股份的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2025/4/30 | | --- | --- | | 回购方案实施期限 | 2025/4/28~2026/4/27 | | 预计回购金额 | 1, ...

南新制药公告，公司于2025年5月30日以集中竞价交易方式首次回购股份14.21万股，占公司总股本2.74 亿股的0.05%，回购价格区间为7.02元/股至7.11元/股，累计使用资金100.38万元(不含交易费用)。此次 回购符合相关法律法规及公司回购方案要求，旨在实施股权激励或员工持股计划。 ...